Research output per year
Research output per year
Personal profile
Education
PhD. KAIST, Korea, 1991
MS, KAIST, Korea, 1987
Pharm B, Department of Pharmacy, Seoul National University,, Korea, 1985
Principle Researcher (Mar 2006 ~ Dec 2024), Korea Institute of Radiological & Medical Sciences, Seoul, Korea
BK21 Associate Professor (Mar. 2002 ~ Feb. 2006), Department of Nuclear Medicine,
College of Medicine, Seoul National University, Seoul, Korea
Research Fellow (1999 ~ Sep. 2001), KAIST, Korea
Research Fellow (March, 1991 ~ Sep. 1999), Korea Research Institute of Bioscience & Biotechnology, Korea
MS, KAIST, Korea, 1987
Pharm B, Department of Pharmacy, Seoul National University,, Korea, 1985
Principle Researcher (Mar 2006 ~ Dec 2024), Korea Institute of Radiological & Medical Sciences, Seoul, Korea
BK21 Associate Professor (Mar. 2002 ~ Feb. 2006), Department of Nuclear Medicine,
College of Medicine, Seoul National University, Seoul, Korea
Research Fellow (1999 ~ Sep. 2001), KAIST, Korea
Research Fellow (March, 1991 ~ Sep. 1999), Korea Research Institute of Bioscience & Biotechnology, Korea
Research Interests
Development of radiopharmaceutical (64Cu-NOTA-Trastuzumab) for HER2 Targeting
Multimodal Molecular Imaging with reporter gene expression
ADME evaluation of New Drugs with RI-labeling method
Multimodal Molecular Imaging with reporter gene expression
ADME evaluation of New Drugs with RI-labeling method
Major Research Achievements
1. Development of radiopharmaceutical (64Cu-NOTA-Trastuzumab) for HER2 Targeting
2. Multimodal Molecular Imaging with reporter gene expression
3. ADME evaluation of New Drugs with RI-labeling method
2. Multimodal Molecular Imaging with reporter gene expression
3. ADME evaluation of New Drugs with RI-labeling method
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 7 Affordable and Clean Energy -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 12 Responsible Consumption and Production
Fingerprint
Dive into the research topics where Joo Hyun Kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluating 64Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a head-to-head comparison with 18F-fluorodeoxyglucose PET/computed tomography
Lee, I., Byun, B. H., Kim, B. I., Choi, C. W., Kang, H. J., Kang, C. S., Woo, S. K., Lee, K. C., Kang, J. H. & Lim, I., Oct 2024, In: Nuclear Medicine Communications. 45, 10, p. 865-873 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Feasibility Study of Single-Photon Emission Computed Tomography with Iodine-123 Labeled Metaiodobenzylguanidine for Preclinical Evaluation of Labetalol as a β-Adrenergic Receptor Blocker
Choi, Y., Lee, E. S., Woo, S. K., Lee, K. C., Chung, H. K. & Kang, J. H., 6 May 2024, In: Molecular Pharmaceutics. 21, 5, p. 2435-2440 6 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Dilute lattice doping of 64Cu into 2D-nanoplates: its impact on radio-labeling efficiency and stability for target selective PET imaging
Eom, S., Kim, M. H., Yoo, R., Choi, G., Kang, J. H., Lee, Y. J. & Choy, J. H., 22 Jul 2022, In: Journal of Materials Chemistry B. 10, 45, p. 9389-9399 11 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Therapeutic Response Monitoring with 89Zr‐DFO‐Pertuzumab in HER2‐Positive and Trastuzumab‐Resistant Breast Cancer Models
Kang, M., Shin, J. I., Han, S., Kim, J. Y., Park, J., Kim, K. I., Kang, J. H. & Lee, T. S., Jul 2022, In: Pharmaceutics. 14, 7, 1338.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
Lee, I., Lim, I., Byun, B. H., Kim, B. I., Choi, C. W., Woo, S. K., Lee, K. C., Kang, J. H., Kil, H. S., Park, C., Chi, D. Y., Park, J., Song, K. & Lim, S. M., Jan 2021, In: European Journal of Nuclear Medicine and Molecular Imaging. 48, 1, p. 95-102 8 p.Research output: Contribution to journal › Article › peer-review
17 Scopus citations